CIK 0002058707 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Attovia Therapeutics, Inc.
Sign in to watch- Ticker
- ATTO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 921510574
- Phone
- 5103995001
- Business address
- 1091 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-06 | Frazier Life Sciences XI, L.P. 10% owner | Purchase | +588,235 | $17.00 | $10.0M | 6,154,213 |
| 2026-08-06 | Frazier Life Sciences XI, L.P. 10% owner | Conversion · Series A-1 Preferred Stock | −16,250,000 | 0 | ||
| 2026-08-06 | Frazier Life Sciences XI, L.P. 10% owner | Conversion · Series A-2 Preferred Stock | −14,772,727 | 0 | ||
| 2026-08-06 | Frazier Life Sciences XI, L.P. 10% owner | Conversion · Series B Preferred Stock | −11,054,544 | 0 | ||
| 2026-08-06 | Frazier Life Sciences XI, L.P. 10% owner | Conversion · Series C Preferred Stock | −8,930,685 | 0 | ||
| 2026-08-05 | WALSH COLIN Director | Purchase | +85,000 | $21.00 | $1.8M | 85,000 |
| 2026-08-05 | WALSH COLIN Director | Sale | −988 | $22.03 | $22K | 84,012 |
| 2026-08-05 | WALSH COLIN Director | Sale | −447 | $21.87 | $10K | 83,565 |
| 2026-08-05 | WALSH COLIN Director | Sale | −1,332 | $22.03 | $29K | 82,233 |
| 2026-08-05 | WALSH COLIN Director | Sale | −200 | $22.05 | $4K | 82,033 |
| 2026-08-05 | WALSH COLIN Director | Sale | −1,556 | $22.06 | $34K | 80,477 |
| 2026-08-05 | WALSH COLIN Director | Sale | −3,402 | $22.02 | $75K | 77,075 |
| 2026-08-05 | WALSH COLIN Director | Sale | −200 | $22.10 | $4K | 76,875 |
| 2026-08-05 | WALSH COLIN Director | Sale | −480 | $21.55 | $10K | 76,395 |
| 2026-08-05 | WALSH COLIN Director | Sale | −100 | $22.11 | $2K | 76,295 |
| 2026-08-05 | WALSH COLIN Director | Sale | −753 | $21.97 | $17K | 75,542 |
| 2026-08-05 | WALSH COLIN Director | Sale | −672 | $22.02 | $15K | 74,870 |
| 2026-08-05 | WALSH COLIN Director | Sale | −6,970 | $22.03 | $154K | 67,900 |
| 2026-08-05 | WALSH COLIN Director | Sale | −400 | $22.02 | $9K | 67,500 |
| 2026-08-05 | WALSH COLIN Director | Sale | −1,180 | $21.84 | $26K | 66,320 |
Page 3 of 9 · 162 trades